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Abstract
Background: Possibilities for biomaterials to impact the dental caries epidemic are reviewed with
emphasis placed on novel delivery biomaterials and new therapeutic targets.
Introduction
The Problem
Although significant progress has been made in reducing
and controlling dental caries, the disease still remains a
problem for many children and adults in the United
States. The problem is much worse for children from poor
families. More than a third of all children 2 to 9 years old
living in poverty in the U.S. have one or more untreated
primary teeth that are affected with caries. There are signif-
icant and persistent racial disparities in dental health and
treatment.
Dental caries is an infectious, communicable disease
resulting in destruction of tooth structure by acid-forming
bacteria found in dental plaque, an intraoral biofilm. The
disease results in tooth loss if left untreated. Fluoride in
the mouth can inhibit demineralization in early carious
lesions and promote remineralization – leading to rebuilt
and stronger outer layers of the tooth (i.e., enamel on the
crown of the tooth and cementum on the root). Water
fluoridation, use of other fluoride therapies such as daily
tooth brushing with fluoride-containing toothpaste,
placement of dental sealants and fluoride-releasing filling
materials, and other appropriate oral health care
approaches currently are utilized in the prevention and
control of dental caries. The mainstays of caries preven-
tion, topical and systemic fluorides and pit and fissure
sealants, are technologies developed in the 1950s and
1960s. Nevertheless, the relapse rates for children who
have been treated for advanced caries are very high.
Science and technology have not produced sufficient prac-
tical tools for public health practitioners and the private
delivery system to address the pandemic in dental caries
that exists for children and adults from families with low
incomes and for numerous ethnic and racial minority
groups. Moreover, it is unclear whether the barriers are
remediable bioengineering and technical problems or
fundamental science questions. Nevertheless, the obliga-
tion to address the gap between scientific research and
practical application is especially relevant today. The fed-
eral government and state governments bear the majority
of the cost of trying to control this pandemic through
Medicaid, the Public Health Service, Indian Health Serv-
ice, and other public programs. These costs continue to
from Biotechnology and Biomaterials to Reduce the Caries Epidemic
Seattle, USA. 13–15 June 2005
Published: 10 July 2006
BMC Oral Health 2006, 6(Suppl 1):S15 doi:10.1186/1472-6831-6-S1-S15
<supplement> <title> <p>Biotechnology and Biomaterials to Reduce the Caries Epidemic</p> </title> <editor>Rebecca L Slayton, James D Bryers, Peter Milgrom</editor> <note>Proceedings</note> <url>http://www.biomedcentral.com/content/pdf/1472-6831-6-S1-info.pdf</url> </supplement>
© 2006 Bryers and Ratner; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Oral Health 2006, 6:S15
Page 2 of 6
(page number not for citation purposes)
escalate, and continued applications of existing technol-
ogy are unlikely to reduce these disparities.
This paper reviews emerging biomaterials technologies
that may be translated into strategies for more effective
means of controlling oral biofilms, dental caries, and per-
iodontal disease.
Processes Governing Biofilm Formation
Microbial cells (predominantly bacteria) in an extracellu-
lar polymer substratum are called biofilms [1]. Complex
physical, chemical, and biological processes govern bacte-
rial attachment, biofilm formation, and persistence [1].
The following fundamental processes comprise the devel-
opment of a bacterial biofilm: (1) Substratum pre-condi-
tioning by circumstantial or pre-meditated adsorption of
fluid phase organic molecules; (2) bacterial cell transport
to the surface; (3) cell desorption from the substratum;
(4) permanent cell adhesion to the substratum; (5) bacte-
rial metabolism (cell substrate conversion; cell growth
and replication; extracellular exopolymer production; cell
starvation, death, lysis); and (6) biofilm removal (cell and
biofilm detachment; biofilm sloughing). Naturally, the
relative influence of each process is dependent upon the
specific system, the prevailing environmental conditions,
and biological changes throughout the lifetime of the bio-
film.
A diverse community of bacteria comprises tooth plaque
biofilm. Early tooth colonizers (e.g., Streptococcus, Hemo-
philus, Neisseria, and Veillonella) adhere to enamel pellicle
protein layers via specific and non-specific adhesion
mechanisms. Subsequently, other species adhere to the
developing biofilm. Once established, the biofilm flora
remain relatively stable, despite periodic perturbations in
the environment. Oral microbial disease is associated
with major shifts in the biofilm ecology. Dental caries is
associated with an increased frequency of consumption of
fermentable sugars in the diet, which results in an increase
in the acidogenic and aciduric species (e.g., S. mutans,
Lactobaccilli). Factors affecting dental plaque include fer-
mentable sugars, low pH, redox potential, and ambient
nutrients.
Emerging Approaches to Dental Caries Prevention
In the last 30 years a number of community- and individ-
ual-level strategies for preventing caries, notably water
fluoridation and fluoridated toothpastes, have been
highly successful. In light of fluoridation's success, a
number of interventions have arisen for primary preven-
tion of dental caries in individual at-risk patient groups.
Regretably, these interventions have existed for some time
and are still inadequate to resolve the caries pandemic in
disparity populations. These existing interventions
include: application of acidulated phosphate fluoride gel
(APF), fluoride varnish, chlorhexidine varnishes and gels
(not available in the United States), pit and fissure seal-
ants, and the use of dentrifices and other products con-
taining antimicrobials (e.g., triclosin and sanguinaria),
noncariogenic sweeteners (e.g., xylitol), or agents to pro-
mote remineralization (e.g., Enamelon toothpaste). Fluo-
ride reservoir systems, developed for post radiation cancer
patients, successfully controlled caries but were never
brought to market.
A number of the key processes controlling biofilm forma-
tion provide targets for application of novel preventive or
remedial technologies (Table 1). Given the increasing use
of relatively invasive medical and surgical procedures, the
material properties of medical devices have received much
attention, as have strategies to target antimicrobials to pre-
vent device-related infections. Dental plaque and oral
hygiene would appear to be obvious therapeutic targets
for the application of novel anti-infective strategies.
Prospects include: (i) materials or surface coatings that
prevent bacterial adhesion, (ii) surfaces that phase change
upon command, and (iii)  passive or active controlled
release of anti-infective agents.
Table 1: Potential strategies to reduce or eliminate bacterial biofilms
Process contributing to Net Biofilm Accumulation Potential Interventions
Substratum pre-conditioning Change surface chemistry; non-fouling surfaces vs. signal decorated 
surfaces
Cell Deposition Maintain sterility
Reversible adhesion Irreversible adhesion Desorption Change surface chemistry or surface topography. Tethered or released 
toxic agent(s). Base material degradable. External toxic challenge. 
Specific adhesin blockers
Cell Signaling Signal analogs; receptor blocking.
Cell Metabolism Antibiotic challenge; starvation, chelator challenge; bacteriophage 
infection, bacteriophage lytic enzymes, device surgical removal
Biofilm Removal Antibiotic challenge; starvation, chelator challenge; bacteriophage 
infection, bacteriophage lytic enzymes, device surgical removalBMC Oral Health 2006, 6:S15
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Materials or Surface Coatings That Prevent Bacterial 
Adhesion
When applied to surfaces or incorporated directly within
the biomaterial, poly(ethylene oxide) (PEO) can inhibit
protein adsorption and bacterial adhesion. This polymer
and its derivatives can be very effective in reducing adhe-
sion from 60–90% for a variety of bacterial species.
For example, we have developed PEO-like oligoglyme
coatings [CH3-O-(CH2-CH2-O) n-CH3, in which n = 1–4],
using radio frequency gas plasma discharge techniques
that can apply these coating to a variety of base materials
[2]. The degree to which this family of coatings protects
surfaces depends in part on which oligomer is used and
what bacterial species is being used. In our studies with
Pseudomonas aeruginosa, a tetraglyme (n = 4) coating can
reduce colonization by 99% relative to uncoated controls.
In other experiments, tetraglyme was deposited on glass
in a pattern using photolithographic methods before
exposure to a suspension of Methylobacterium extorquens.
After 72 hours, almost all of the bacteria were adhering to
the bare glass, with very few bacteria on the glyme-coated
regions.
The elegance of the RF plasma technique is that such PEG-
like coatings can be deposited onto a variety of existing
materials and geometric shapes (e.g., inside and outside of
catheters, porous scaffold structures, metals, polymers,
ceramics, orthodontic materials, and enamel). Although
such glyme-plasma coatings resist protein adsorption for
at least one week, longer-term bacterial challenges are
needed to more fully evaluate these coatings.
Surfaces That Change Phase on Command
The surface-grafted thermally responsive polymer poly(N-
isopropyl acrylamide) (PNIPAM) has a critical-solubility
temperature of about 32°C, making it insoluble in water
at temperatures above 32°C but soluble at temperatures
below 32°C.
In lab tests, >90% of microorganisms (Staphylococcus epi-
dermidis,  Halomonas marina) and naturally-occurring
marine microorganisms that attached to PNIPAM grafted
to polystyrene surfaces were removed immediately when
the hydration state of the polymer was changed by simply
rinsing the samples in cold (4°C) water [3]. Confluent
sheets of mammalian cells can also be rapidly detached
from similar PNIPAM-grafted surfaces when the tempera-
ture is shifted from 37°C to room temperature. Whether
temperature changes can remove thick bacterial biofilms
from such surfaces remains to be evaluated.
Passive or Active Controlled Release of Anti-infective 
Agents
There are numerous biomaterials platforms that have
been used for decades for the controlled delivery of drugs
including cancer chemotherapies, birth control, insulin,
anti-viral agents, analgesics, antibiotics, and cosmetics.
Journals such as the Journal of Biomedical Materials
Research,  Biomaterials, and Journal of Controlled Release
have been filled for decades with the scientific advances in
controlled-therapy release. Many of these publications
deal with oral biomaterials and oral hygiene but have
unfortunately escaped the attention of most dental profes-
sionals.
Regrettably, due to page limits, this paper cannot possibly
review even a fraction of the drug delivery systems availa-
ble. The reader is directed to several reviews on this topic
[4-9]. Here we will discuss the various types of controlled-
release systems available (passive versus controlled or
activated) and enumerate the possible agents that could
be released to control dental caries.
Passive Delivery Systems
A convenient classification of controlled-release systems is
based on the mechanism that controls the release of the
substance in question. The most common mechanism is
diffusion. Two types of diffusion-controlled systems have
been developed; the first is a reservoir device in which the
bioactive agent (drug) forms a core surrounded by an
inert diffusion barrier. These systems include membranes,
capsules, microcapsules, liposomes, and hollow fibers.
The second type is a monolithic device in which the active
agent is dispersed or dissolved in an inert polymer. As in
reservoir systems, drug diffusion through the polymer
matrix is the rate-limiting step, and release rates are deter-
mined by the choice of polymer and its consequent effect
on the diffusion and partition coefficient of the drug to be
released.
In chemically controlled systems, chemical control can be
achieved using bioerodible or pendant chains. The ration-
ale for using bioerodible (or biodegradable) systems is
that the bioerodible devices are eventually absorbed by
the body and thus need not be removed surgically. Bioero-
sion can be defined as the conversion of a material that is
insoluble in water into one that is water-soluble. In
bioerodible systems the drug is ideally distributed uni-
formly throughout a polymer in the same way as in mon-
olithic systems. As the polymer surrounding the drug is
eroded, the drug escapes. In a pendant chain system, the
drug is covalently bound to the polymer and is released by
bond scission, either hydrolytically or enzymatically. In
solvent-activated controlled systems, the active agent is
dissolved or dispersed within a polymeric matrix and isBMC Oral Health 2006, 6:S15
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not able to diffuse through that matrix. As the environ-
mental fluid (e.g. water) penetrates the matrix, the poly-
mer swells and its glass transition temperature is lowered
below the environmental (host) temperature. Thus, the
swollen polymer is in a rubbery state and allows the drug
contained within to diffuse through the encapsulant.
Responsive Drug Delivery Systems
Responsive drug-delivery systems can be classified as
open- or closed-loop systems. Open-loop systems are also
called pulse or externally regulated systems; the rate of
drug released is not dependent upon environmental con-
ditions. The rate of drug released can be controlled and
enhanced using external stimulants, such as magnetism
and ultrasound. In magnetically-controlled drug delivery
devices, small magnetic spheres are embedded in a drug-
containing polymer. These spheres release a significant
amount of drug when exposed to an oscillating field. Sim-
ilarly, the release rate also increases when analogous drug-
containing polymers are exposed to ultrasound. Ultra-
sound was found to enhance erosion and degradation of
some biodegradable polymers [10] It also can act as an
on-off switch as in certain drug delivery systems being
developed in the University of Washington Engineered
Biomaterials (UWEB) Center [11,12].
In closed-loop systems, or self-regulated systems, the
release is in direct response to the conditions detected, be
it temperature, type of solvent, pH, or concentration, to
name a few. Poly(N-isopropylacrylamide) is a well-
known example of a thermo-responsive polymer. At its tran-
sition of 32°C, the polymer is soluble in water; but, as
temperature is increased, the polymer precipitates and
phase separates. Poly(ethylene glycol) and poly(propyl-
ene glycol) copolymers as well as poly(lactic acid) and
poly(glycolic acid) copolymers also exhibit thermo-
responsiveness. These polymers are useful in developing
thermogelling systems (e.g., Atridox®), in which the drug
is initially dissolved in the liquid form of the polymer at
room temperature. When this mixture is injected into the
body at 37°C, the polymer turns into a gel, which eventu-
ally degrades and releases the drug molecules.
Self-regulating insulin-delivery devices depend on the
concentration of glucose in the blood to control the
release of insulin. One proposed system would immobi-
lize glucose oxidase (an enzyme) to a pH-responsive pol-
ymeric hydrogel, which encloses a saturated insulin
solution. At high glucose levels, glucose is catalyzed by
glucose oxidase which converts it to gluconic acid, thus
lowering the pH. This decrease in pH would cause the
membrane to swell, forcing the insulin out of the device
[13,14]. A similar pH responsive material could deliver
"on-demand" anti-caries therapy at the first drop in pH.
Anti-caries Therapeutics for Controlled Release
The chemical properties (hydrophobic vs. hydrophilic) of
therapeutic agents selected for release will determine to
some extent the possible controlled release system
selected [15]. Numerous types of agents could be incorpo-
Table 2: Anti-caries Therapeutics for Controlled Release
Agent Released Mode of Action Relative Costs Reference
Fluoride mixed mode low Aaltonen et al., 2000 [18]
Chlorhexidine disinfectant low Twetman, 2004 [19]
Xylitol noncariogenic sweeteners low Smits & Arends, 1985. [20]
Tanzer, 1995 [21]
Commercial antibiotics mixed targets moderate
Anti-bacterial peptides (defensins, 
magainin derivatives, bacteriocins 
and cecropins)
cell membrane perforation moderate/high Otvos et al., 2004 [22]
Ericksen et al., 2005 [23]
pH Buffers maintain non-acidic pH low Lynch, 2004 [24]
Chelators (EGTA) strips Ca+2 from biofilm 
polysaccharide; causes biofilm 
disruption
low Ozerdem et al., 2003 [25]
Raad et al., 2003 [26]
Polysaccharide modifiers (lyase, 
AlCl3)
moderate Albrecht and Schiller, 2005 [27]
Stoodley et al., 2001 [28]
Enzymes (proteases) enzymatically degrades cell walls 
and adhesin proteins
moderate/high Berg et al., 2001 [29]
Johansen et al., 1997 [30]
Sato et al., 1983 [31]
Quorum sensing analogs 
(furanones, salicylic acid)
negates las and Rhl regulon 
systems, down-regulates 
polysaccharide synthesis
moderate/high Daniels et al., 2004 [32]
Baveja et al., 2004 [33]
Anti-adhesin blockers negates specific adhesion of select 
bacteria to exclusive ligand
high Hajishengallis et al., 1992 [34]BMC Oral Health 2006, 6:S15
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rated in a new generation of biomaterials for the preven-
tion of dental caries. For the sake of brevity, these agents
are simply listed with their mode of action in Table 2.
An example of such a system developed to eradicate bio-
films involves liposomal delivery. Jones and colleagues
have reported extensive studies of the interaction between
liposomes and bacterial biofilms. Interestingly, when tar-
geting mixed biofilms of Streptococcus sanguis and S. sali-
varius  with liposomes loaded with the bactericide
triclosan, anionic liposomes were most effective against S.
sanguis but relatively ineffective against S. salivarius [16].
An additional approach has been to load antibacterials
into liposomes adsorbed on the surface of zinc citrate par-
ticles, as used in toothpaste formulations, to produce
solid supported vesicles containing either triclosan or
aqueous-soluble penicillin-G. Other oral hygiene
approaches have included liposomal encapsulation of the
enzyme glucose oxidase and horseradish peroxidase. This
process generates hydrogen peroxide and oxyacids in the
presence of their substrates. These liposome systems were
effective against S. gordonii biofilms in a manner depend-
ent upon liposome-biofilm and substrate-biofilm incuba-
tion times [17].
Conclusion
Increasing scientific research over the past 10 years in bio-
film formation, especially in the oral cavity, has provided
a wealth of possible targets with which to eradicate dental
caries. Advances in the understanding of biofilm forma-
tion, coupled with emerging engineered biomaterials,
provides many potential platforms and strategies that may
be applied to prevent dental caries in susceptible popula-
tions.
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